Seventh Sense - Unlocking the Value of Blood Testing
With its proprietary TAP Touch Activated Phlebotomy™ painless blood sampling technology, Seventh Sense is unlocking access to vital blood test information across settings of care and ultimately all the way to the home.
Seventh Sense Lead Product: TAP 20™ for Point of Care Testing
Seventh Sense's first marketed product will collect up to 20 microliters of blood, enough for many common physician office point of care tests. With pain-free TAP collection, point of care testing will be made easier for both clinicians and patients.
Company News
- Press Release – April 2, 2013
Seventh Sense Biosystems Announces Initiation of Registration Trial for Painless TAP™ Blood Collection Device Read more »
- Seventh Sense in the News – July 12, 2012
Seventh Sense's TAP painless blood collection technology featured on WBZ News. Read More »
- Press Release – June 13, 2012
Howard Weisman joins Seventh Sense Biosystems as Chief Executive Officer and President, Company completes $10 million Series-A financing Read more »
- Press Release – December 16, 2011
Seventh Sense Biosystems Receives $3.28 Million Grand Challenges Point-of-Care Diagnostics Grant to Expand TAP Touch Activated Phlebotomy™ Read more »
Edison Awards – April 8, 2011
Seventh Sense Biosystems' TAP blood access technology wins gold medal at 2011 Edison Awards Read more »
